Barclays raised the firm’s price target on Novo Nordisk to DKK 1,350 from DKK 1,200 and keeps an Overweight rating on the shares.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NVO:
- Novo Nordisk price target raised to DKK 1,450 from DKK 1,200 at Deutsche Bank
- Novo Nordisk price target raised to DKK 1,200 from DKK 1,075 at Barclays
- Novo Nordisk raises sales and operating profit outlook for 2023
- Novo Nordisk upgraded to Outperform from Neutral at Credit Suisse
- Novo Nordisk, Aspect Biosystems announce bioprinted tissue partnership
